SPRUCE BIOSCIENCES, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for SPRUCE BIOSCIENCES, INC. (SPRB), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are SPRB insiders buying or selling?
SPRUCE BIOSCIENCES, INC. insiders reported no open-market purchases or sales in the last 12 months. Since October 2020, Trabud has recorded 18 Form 4 filings for SPRB: 10 buys ($38.2M) and 8 sells ($10.2M).
Source: SEC EDGAR Form 4
Key Statistics (October 2020 – Oct 15, 2025)
Total Form 4 filings
18
SEC EDGAR
Insider filers
10
Insider buys (10)
$38.2M
Insider sells (8)
$10.2M
Insider sentiment
Net buyingNet insider flow of $28.0M in net buying since October 2020.
Recent SPRB insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 15, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sale | 1 | $334.95 | $334.95 | SEC ↗ |
| Oct 9, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sale | 1 | $334.95 | $334.95 | SEC ↗ |
| Mar 26, 2024 | Novo Holdings A/S | 10% Owner | Sale | 465.0K | $0.75 | $351.0K | SEC ↗ |
| Mar 21, 2024 | Novo Holdings A/S | 10% Owner | Sale | 1.8M | $0.76 | $1.4M | SEC ↗ |
| Mar 19, 2024 | Novo Holdings A/S | 10% Owner | Sale | 1.9M | $0.89 | $1.7M | SEC ↗ |
| May 16, 2023 | Niall O'Donnell | Director | Purchase | 630.4K | $3.17 | $2.0M | SEC ↗ |
| Feb 21, 2023 | Novo Holdings A/S | 10% Owner | Purchase | 2.2M | $3.17 | $7.0M | SEC ↗ |
| May 22, 2021 | Camilla V Simpson | Director | Sale | 334 | $15.29 | $5.1K | SEC ↗ |
| May 21, 2021 | Novo Holdings A/S | 10% Owner | Sale | 475.0K | $13.90 | $6.6M | SEC ↗ |
| May 5, 2021 | Camilla V Simpson | Director | Sale | 14.0K | $16.14 | $226.7K | SEC ↗ |
| Oct 16, 2020 | Novo Holdings A/S | 10% Owner | Purchase | 250.0K | $15.00 | $3.8M | SEC ↗ |
| Oct 16, 2020 | RiverVest Venture Fund III, L.P. | 10% Owner | Purchase | 250.0K | $15.00 | $3.8M | SEC ↗ |
| Oct 16, 2020 | Bali Muralidhar | Director | Purchase | 200.0K | $15.00 | $3.0M | SEC ↗ |
| Oct 16, 2020 | Niall O'Donnell | Director | Purchase | 250.0K | $15.00 | $3.8M | SEC ↗ |
| Oct 16, 2020 | Omega Fund VI, L.P. | Other | Purchase | 250.0K | $15.00 | $3.8M | SEC ↗ |
| Oct 16, 2020 | Moghrabi Dina Chaya | Director | Purchase | 250.0K | $15.00 | $3.8M | SEC ↗ |
| Oct 16, 2020 | HealthCap VIII, L.P. | Other | Purchase | 250.0K | $15.00 | $3.8M | SEC ↗ |
| Oct 16, 2020 | Jonas Hansson | Director | Purchase | 250.0K | $15.00 | $3.8M | SEC ↗ |
Showing the 18 most recent of 18 Form 4 filings for SPRUCE BIOSCIENCES, INC..
Most active SPRB insiders
- Novo Holdings A/S6 filings
- Camilla V Simpson2 filings
- Niall O'Donnell2 filings
- Parkman Healthcare Partners LLC2 filings
- Bali Muralidhar1 filing
Ask anything about SPRB insider activity
Use Trabud's AI agent to query SPRUCE BIOSCIENCES, INC.'s Form 4 history in plain English — "Show me SPRB CEO purchases this year" or compare it against any other ticker.
Open the AI agentSPRB insider trading FAQ
Are SPRUCE BIOSCIENCES, INC. insiders buying or selling?
SPRUCE BIOSCIENCES, INC. insiders reported no open-market purchases or sales in the last 12 months. Since October 2020, Trabud has recorded 18 Form 4 filings for SPRB: 10 buys ($38.2M) and 8 sells ($10.2M). Over the full record that is net buying of $28.0M.
How many insiders trade SPRB stock?
10 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for SPRUCE BIOSCIENCES, INC.. The most recent filing was accepted on Oct 15, 2025.
Where does Trabud get SPRB insider trading data?
All SPRB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.